Cancer Detection and Diagnosis Research in North Carolina
Cancer Detection and Diagnosis Research (93.394) awarded $76.0 million to recipients in North Carolina in 68 grants from fiscal 2021 to 2025, 2.8% of the program's national total. Duke University received the most, $31.6 million.
- Awarded in North Carolina$76.0 million
- Awards68
- Share of the program2.8%
- Rank among states11th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 27 | $10.9 million |
| FY 2022 | 29 | $12.9 million |
| FY 2023 | 33 | $14.7 million |
| FY 2024 | 31 | $13.5 million |
| FY 2025 | 35 | $24.0 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Duke University | Colleges and universities | 25 | $31.6 million |
| University of North Carolina at Chapel Hill | Colleges and universities | 18 | $20.8 million |
| Wake Forest University Health Sciences | Colleges and universities | 5 | $4.9 million |
| North Carolina State University | Colleges and universities | 3 | $4.7 million |
| Ramona Optics Inc | Small businesses | 2 | $2.4 million |
| Calla Health Foundation, Inc | Small businesses | 2 | $2.3 million |
| Akrotome Imaging, Inc | Small businesses | 1 | $1.8 million |
| Epicypher, Inc. | Small businesses | 2 | $1.5 million |
| Data Driven Bioscience Inc | Small businesses | 2 | $1.3 million |
| Triangle Biotechnology, Inc | Small businesses | 1 | $1.2 million |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to North Carolina?
$76.0 million from fiscal 2021 to 2025, across 68 awards. North Carolina ranks 11th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in North Carolina?
The largest recipient is Duke University, with $31.6 million in 25 awards. Next are University of North Carolina at Chapel Hill and Wake Forest University Health Sciences.
Can organizations in North Carolina apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States